| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |